Ambamustine
Alternative Names: PTT 119Latest Information Update: 23 Jan 2013
At a glance
- Originator Proter
- Developer Abbott GmbH & Co. KG
- Class Antineoplastics; Nitrogen mustard compounds
- Mechanism of Action Alkylating agents; DNA cross linking agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Non-Hodgkin's lymphoma; Small cell lung cancer